Home » EU Agency Backs Novartis’ Votubia for Kidney Tumors
EU Agency Backs Novartis’ Votubia for Kidney Tumors
European regulators on Friday recommended approval of a Novartis’ drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex.
Reuters
Reuters
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May